Description
A potent DPP-4 inhibitor (IC50 = 1 nM for human recombinant DPP-4); ≥10,000-fold selectivity for DPP-4 over other a panel of 11 peptidases and proteases; inhibits 90% of plasma DPP-4 activity in rat; dose-dependently decreases plasma glucose and increases plasma levels of GLP-1 and insulin in Zucker diabetic fatty rats; reduces HbA1c levels in mice with high-fat diet- and low-dose streptozotocin-induced diabetes
Formal name: 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
Synonyms: BI-1356
Molecular weight: 472.5
CAS: 668270-12-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes